4.10.15.1Vertical
Community Oncology Practices
Independent and PE-backed community cancer treatment practices.
Market snapshot
These figures describe Oncology & Cancer Care (4.10.15), the segment that Community Oncology Practices sits within — not Community Oncology Practices on its own.
FragmentationConsolidatingEstimate
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so oncology is not separately sized.
Business model & economics
Revenue model
Drug margin (buy-and-bill), services, and radiation
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- Drug-margin- and site-of-care-driven
- Capex intensity
- Moderate
recurring treatment courses
Characteristics
- Consolidated around large community-oncology networks.
- Drug margin and site-of-care economics are central.
- Value-based oncology models emerging.
M&A deal context
Deal activityHigh
Who’s acquiring
- Community-oncology networks
- PE- and distributor-backed platforms
- Value-based oncology acquirers
What’s driving deals
- Consolidation around oncology networks.
- Site-of-care and drug-margin economics.
- Rising cancer incidence and novel therapies.
Find Community Oncology Practices acquisition targets
Search Acquisera’s index for companies classified under Community Oncology Practices (4.10.15.1) and build a targeted deal pipeline.
Search companies